Rare disease specialist and leader who turns hope into action for long-term sufferers
Right to left: Physician-scientist & author, David Fajgenbaum & Mobilium Global CEO Ralph Simon. David was suffering from a deadly disease until he discovered a life-saving treatment by repurposing an existing drug. That led him to co-found Every Cure, which searches for hidden treatments in FDA-approved medications, pioneering a brilliant new field called “Computational Pharmacophenomics”. Every Cure will use AI to accelerate the discovery of new uses for generic & off‑patent drugs, democratising access to safe & effective treatments – saving lives & making David a global inventor of distinction.
